We are live on ! Find out more
RVM

RiverVest Venture Management Portfolio holdings

AUM $6.84M Turnover 25%
1-Year Est. Return 7.71%
This Fund
S&P 500
This Quarter Est. Return
+13.45%
1 Year Est. Return
-7.71%
3 Year Est. Return
-16.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$85.7M
AUM Growth
-$403K
Cap. Flow
-$5.93M
Cap. Flow %
-6.92%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
1
Closed
–
Avg Time Held
1.8 years
Top 10 Avg Time Held
1.8 years
Top 20 Avg Time Held
1.8 years

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
MIRM icon
Mirum Pharmaceuticals
MIRM
+$5.93M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ALLK icon
1
DELISTED
Allakos
ALLK
$41.2M 48.01%
4,887,932
– –
2020 Q4
8 quarters
MIRM icon
2
Mirum Pharmaceuticals
MIRM
$5.35B
$31.6M 36.87%
1,621,118
-300,000
-16% -$5.93M
2020 Q4
8 quarters
OKUR icon
3
OnKure Therapeutics
OKUR
$86.3M
$5.61M 6.55%
240,922
– –
2021 Q2
6 quarters
XLO icon
4
Xilio Therapeutics
XLO
$59.4M
$3.88M 4.52%
102,960
– –
2021 Q4
4 quarters
SPRB icon
5
Spruce Biosciences
SPRB
$119M
$2.36M 2.75%
28,644
– –
2020 Q4
8 quarters
VAPO
6
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$1.11M 1.3%
51,570
– –
2020 Q4
8 quarters

Similar funds

JDR
Jay D. Rosenbaum $6.69M AUM 4.68% 1-Year Est. Return
KIM
Kaizen Investment Management Singapore $6.23M AUM
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
HVM
Harvest Volatility Management Norwalk, Connecticut $4.39M AUM 13.08% 1-Year Est. Return
BGC
Birch Grove Capital New York $9.51M AUM 0.22% 1-Year Est. Return
QC
QCM Cayman Houston, Texas $3.63M AUM 61.13% 1-Year Est. Return
CU
Cornell University New York $3.44M AUM 9.69% 1-Year Est. Return
PWA
Pillar Wealth Advisors West Chester, Pennsylvania $3.35M AUM 22.3% 1-Year Est. Return

RiverVest Venture Management's Q4 2022 Portfolio in Review

As of Q4 2022, RiverVest Venture Management held 6 positions worth $85.7M, down 0.47% from $86.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

RiverVest Venture Management withdrew a net $5.93M in Q4 2022, reducing 1 holding. Its largest reduction was Mirum Pharmaceuticals, cutting an estimated $5.93M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • RiverVest Venture Management's biggest Q4 2022 reduction was Mirum Pharmaceuticals, cutting an estimated $5.93M.
  • RiverVest Venture Management's ten largest holdings make up 100% of its $85.7M portfolio in Q4 2022.
  • RiverVest Venture Management opened 0 new positions and closed 0 in Q4 2022.
  • RiverVest Venture Management's portfolio value fell 0.47% quarter-over-quarter to $85.7M.

Based on RiverVest Venture Management's 13F filing for Q4 2022, filed 14 Feb 2023.